Summary
DexCom, Inc. (DXCM) filed an 8-K on February 9, 2023, to report its financial results for the fourth quarter and full year ended December 31, 2022. The filing primarily consists of a press release detailing these results and related information. While the 8-K itself does not contain the detailed financial tables, it serves as the official notification of the company's performance, directing investors to the furnished press release for specifics. Investors should review the press release (Exhibit 99.1) for comprehensive data on revenue, profitability, and any forward-looking statements made by the company. This report is crucial for understanding DexCom's recent operational and financial standing. The information furnished is not considered "filed" for regulatory purposes under Section 18 of the Exchange Act, but it is the primary source for the company's stated performance metrics and outlook as of the filing date. Investors are advised to consult the actual press release for a complete picture of the company's financial condition and results of operations.
Key Highlights
- 1DexCom, Inc. (DXCM) released its Q4 and Full Year 2022 financial results on February 9, 2023, via an 8-K filing.
- 2The 8-K filing includes a press release (Exhibit 99.1) containing the detailed financial results.
- 3Investors are directed to the furnished press release for specific financial performance data for the periods ended December 31, 2022.
- 4The information provided is furnished and not deemed 'filed' for Section 18 of the Exchange Act.
- 5This filing serves as the official announcement and a key reference point for the company's operational and financial status at the end of 2022.